PU141
PU141 is a selected pyridoisothiazolone HAT inhibitor. PU141 is selective toward CBP and p300. PU141 induces cellular histone hypoacetylation and inhibits growth of several neoplastic cell lines originating from different tissues. Anticancer activity[1].
Product Specifications
CAS Number
168334-34-7
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pu141.html
Purity
99.30
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C1N(SC2=NC=CC=C21)CC3=CC=C(C=C3)C(F)(F)F
Molecular Formula
C14H9F3N2OS
Molecular Weight
310.29
References & Citations
[1] M Gajer, et al. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis.2015 Feb 9;4 (2) :e137.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Rabbit Prenylated Rab acceptor protein 1 (RABAC1) ELISA Kit
LRRN5 (Leucine-rich Repeat Neuronal Protein 2, Glioma Amplified on Chromosome 1 Protein, Leucine-rich Repeat Neuronal Protein 5, LRRN2, GAC1, UNQ256/PRO293) (FITC)
LRRN5 (Leucine-rich Repeat Neuronal Protein 2, Glioma Amplified on Chromosome 1 Protein, Leucine-rich Repeat Neuronal Protein 5, LRRN2, GAC1, UNQ256/PRO293) (FITC)
![Human Placental Villous Cancer Cells [JAR]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)